Contracts › W81K0222P0104
W81K0222P0104: Clinical Chemistry & Immunoassay Reagents and Analyzers
Awarded to Roche Diagnostics Corporation by Defense Health Agency.
$2.9Mobligated
$4.3Mpotential value
30 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W81K0222P0104 |
|---|---|
| Awardee | Roche Diagnostics Corporation |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY HCD WEST |
| NAICS | 325413 In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Place of performance | IN |
| Offers received | 5 |
| Period of performance | 01 October 2022 to 30 September 2026 |
| Potential end | 30 September 2027 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325413 contracts · All expiring contracts · USASpending record